Usama M. Ammar

Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold

Mohammed S. Abdel‐Maksoud, Usama M. Ammar, Chang‐Hyun Oh · Bioorganic & Medicinal Chemistry · 2019 · 45 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +9

Discovery of New Imidazo[2,1-<i>b</i>]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising <i>In Vitro</i> and <i>In Vivo</i> Anti-melanoma Activity

Mohammed S. Abdel‐Maksoud, Mohammed I. El–Gamal, Bong S. Lee et al. · Journal of Medicinal Chemistry · 2021 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor

Eslam M.H. Ali, Mohammed S. Abdel‐Maksoud, Rasha M. Hassan et al. · Bioorganic & Medicinal Chemistry · 2020 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600Einhibitors

Eslam M.H. Ali, Mohammed S. Abdel‐Maksoud, Usama M. Ammar et al. · Bioorganic Chemistry · 2020 · 35 citations

Pharmacy, Chemistry, Medicinal Chemistry +10

Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors

Mohammed S. Abdel‐Maksoud, Usama M. Ammar, Mohammed I. El–Gamal et al. · Bioorganic Chemistry · 2019 · 29 citations

Pharmacy, Medicinal Chemistry, Oncology +11